EXT418 given daily or every other day (EOD) for 2 weeks reduced this drop to 5% and 6%, respectively, although this difference did not reach statistical significance when compared with the T + V group (T + 418 Daily vs.
← all excerpts
EXT418, a novel long-acting ghrelin, mitigates Lewis lung carcinoma induced cachexia in mice.
1
—
—